NOVEL PYRAZOLO[4,3-D]PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND METHODS FOR THERAPY

0110099 - UEB-Q 20043105 RIV CA eng P - Patentový dokument
Kryštof, Vladimír - Lenobel, René - Moravcová, Daniela - Strnad, Miroslav - Havlíček, Libor
NOVEL PYRAZOLO[4,3-D]PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND METHODS FOR THERAPY.
[NOVÉ PYRAZOLO[4,3-D]PYRIMIDINY, POSTUPY JEJICH PŘÍPRAVY A METODY TERAPIE.]
Montreal: Canadian Intellectual Property Office, 2003. Vlastník: Ústav experimentální botaniky AV ČR. Datum podání přihlášky: 29.01.2003. Datum udělení patentu: 06.09.2003. 120 s. Číslo patentu: CA2480409
Výzkumný záměr: CEZ:AV0Z5038910
Klíčová slova: pyrimidines * anticancer drugs
Kód oboru RIV: EB - Genetika a molekulární biologie
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=CA2480409&F=0

The invention relates to 3-, 5-, 7-trisubstituted pyrazolo-4,3-d-pyrimidines represented by the general formula I CHEM and pharmaceutically acceptable salts thereof, wherein R3 is an optionally substituted alkyl, cycloalkyl, cycloheteroalkyl, cycloalkyl alkyl, aryl or alkylaryl group; R5 is halogen, -NHNH2, -NHOH, NHCONH2, guanylo (NH-C(NH)NH2) an optionally substituted C1-C6 alkyl, alkenyl, alkinyl, C3-C15 cycloalkyl, Rf (C3-C15 cycloalkyl), heterocycle, heteroalkyl, aryl, heteroaryl, arylalkyl, cycloheteroalkyl, cycloheteroalkyl alkyl, heteroarylalkyl group, the group -C(O)-Ra, -C(O)NRbRc, -SO3Rd, or -NHC(O)Re, wherein Ra and Rf are an optionally substituted C1-C6 alkyl, alkenyl, or alkinyl group, Rb, Rc and Rd are independently selected from the group consisting of H, optionally substituted C1-C6 alkyl, alkenyl, or alkinyl group, and Re is a hydroxy, amino, alkoxy, alkylamino, optionally substituted C1-C6 alkyl, alkenyl or alkinyl group; or the group -X-R5', wherein X is -NH-, -O-, -S- or -N(alkyl)- and R5' is hydrogen, an optionally substituted C1-C6 alkyl, alkenyl, alkinyl, C3-C15 cycloalkyl, , Rf(C3-C15 cycloalkyl), aryl, heterocycle, hetero C1-C6 alkyl, arylalkyl, heteroaryl, cycloheteroalkyl, cycloheteroalkyl alkyl, or heteroarylalkyl group, the group -C(O)-Ra, -C(O)NRbRc, -SO3Rd, or -NHC(O)Re, wherein Ra, Rb, Rc, Rd, Re and Rf have the above meaning, and R7 is halogen, -NHNH2, NHOH, NHCONH2, guanylo (NH-C(NH)NH2) or the group -X-R7', wherein X has the above meaning and the meaning of R7' is as defined for R5'.

NOVÉ PYRAZOLO[4,3-D]PYRIMIDINY, POSTUPY JEJICH PŘÍPRAVY A METODY TERAPIE
Trvalý link: http://hdl.handle.net/11104/0017192